Format

Send to

Choose Destination
Fertil Steril. 2009 Jun;91(6):2732.e11-4. doi: 10.1016/j.fertnstert.2009.01.104. Epub 2009 Apr 11.

Mitochondrial fatty acid transport enzyme deficiency--implications for in vitro fertilization.

Author information

1
Research Centre for Reproductive Health, Department of Obstetrics and Gynaecology, University of Adelaide, South Australia, Australia. louise.hull@adelaide.edu.au

Abstract

OBJECTIVE:

To describe the individualized clinical and embryologic care required by a patient with adult-onset carnitine palmitoyl transferase II deficiency during IVF treatment and in a subsequent pregnancy.

DESIGN:

A case study.

SETTING(S):

A private fertility unit and public obstetric hospital.

PATIENT(S):

A patient with a rare mutation in the mitochondrial fatty acid transport enzyme, carnitine palmitoyl transferase II.

INTERVENTION(S):

The patient received (IVF) fertility treatment and pregnancy care.

MAIN OUTCOME MEASURE(S):

Pregnancy and delivery of a healthy child.

RESULT(S):

This patient conceived on her first cycle of IVF and went on to deliver a healthy child.

CONCLUSION(S):

Patients with adult-onset carnitine palmitoyl transferase II deficiency can have successful pregnancy outcomes after IVF, provided clinical and embryologic care is optimized.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center